Left ventricular assist devices: From the bench to the clinic

Cardiology (Switzerland)

Volumn 125, Issue 1, 2013, Pages 1-12

  Lee, Sangjin ^a   Fukamachi, Kiyotaka ^a   Golding, Leonard ^a   Moazami, Nader ^b   Starling, Randall C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Heart and Vascular Institute   (United States)

Author keywords

Axial flow devices; Centrifugal flow devices; Continuous flow devices; Mechanical circulatory support; Ventricular assist devices

Indexed keywords

ARTICLE; ASSISTED CIRCULATION; CARDIOVASCULAR RISK; FUNCTIONAL STATUS; HEALTH CARE QUALITY; HEART FAILURE; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; PRIORITY JOURNAL; TOTAL ARTIFICIAL HEART;

EID: 84876080920     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000346865     Document Type: Article

References (46)

1. Roger VL, et al: Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011; 123:e18-e209.
2. McMurray JJ, et al: Clinical epidemiology of heart failure: public and private health burden. Eur Heart J 1998; 19(suppl P):P9-P16.
3. Starling RC, Gorodeski EZ: Potential population for long-term use of left ventricular assist devices; in Kormos RL, Miller LW (eds): Mechanical Circulatory Support: A Companion to Braunwald's Heart Disease. Philadelphia, Saunders, 2011.
4. Frazier OH, et al: Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg 1992; 53: 1080-1090.
5. Korfer R, et al: Single-center experience with the Thoratec ventricular assist device. J Thorac Cardiovasc Surg 2000; 119: 596-600.
6. McBride LR, et al: Clinical experience with 111 Thoratec ventricular assist devices. Ann Thorac Surg 1999; 67: 1233-1238, discussion 1238-1239.
7. Moskowitz AJ, et al: Quality of life with an implanted left ventricular assist device. Ann Thorac Surg 1997; 64: 1764-1769.
8. Pennington DG, et al: Eight years' experience with bridging to cardiac transplantation. J Thorac Cardiovasc Surg 1994; 107: 472-480, discussion 480-481.
9. Portner PM, et al: Implantable electrical left ventricular assist system: bridge to transplantation and the future. Ann Thorac Surg 1989; 47: 142-150.
10. Rose EA, et al: Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345: 1435-1443.
11. Pagani FD: Continuous-flow rotary left ventricular assist devices with '3rd generation' design. Semin Thorac Cardiovasc Surg 2008; 20: 255-263.
12. Wieselthaler GM, et al: First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation. Circulation 2000; 101: 356-359.
13. Westaby S, et al: First permanent implant of the Jarvik 2000 Heart. Lancet 2000; 356: 900-903.
14. Frazier OH, et al: First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: a case report. Tex Heart Inst J 2004; 31: 157-159.
15. Hetzer R, et al: First experiences with a novel magnetically suspended axial flow left ventricular assist device. Eur J Cardiothorac Surg 2004; 25: 964-970.
16. Morshuis M, et al: DuraHeart magnetically levitated centrifugal left ventricular assist system for advanced heart failure patients. Expert Rev Med Devices 2010; 7: 173-183.
17. Baughman KL, Jarcho JA: Bridge to life-cardiac mechanical support. N Engl J Med 2007; 357: 846-849.
18. Kirklin JK, et al: The Fourth INTERMACS Annual Report: 4, 000 implants and counting. J Heart Lung Transplant 2012; 31: 117-126.
19. Miller LW, et al: Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357: 885-896.
20. Slaughter MS, et al: Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361: 2241-2251.
21. Park SJ, et al: Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail 2012; 5: 241-248.
22. Rogers JG, et al: Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 2010; 55: 1826-1834.
23. Starling RC, et al: Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011; 57: 1890-1898.
24. Macris MP, et al: In vivo evaluation of an intraventricular electric axial flow pump for left ventricular assistance. ASAIO J 1994; 40:M719-M722.
25. Nojiri C, et al: Recent progress in the development of Terumo implantable left ventricular assist system. ASAIO J 1999; 45: 199-203.
26. James NL, et al: Implantation of the VentrAssist Implantable Rotary Blood Pump in sheep. ASAIO J 2003; 49: 454-458.
27. van der Meer AL, et al: Initial in vivo experience of the VentrAssist implantable rotary blood pump in sheep. Artif Organs 2003; 27: 21-26.
28. Esmore DS, et al: Initial clinical experience with the VentrAssist left ventricular assist device: the pilot trial. J Heart Lung Transplant 2008; 27: 479-485.
29. Pitsis AA, et al: First human implantation of a new rotary blood pump: design of the clinical feasibility study. Hellenic J Cardiol 2006; 47: 368-376.
30. Tuzun E, et al: In vivo evaluation of the Heart-Ware centrifugal ventricular assist device. Tex Heart Inst J 2007; 34: 406-411.
31. Wieselthaler GM, et al: Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multiinstitutional trial. J Heart Lung Transplant 2010; 29: 1218-1225.
32. Strueber M, et al: Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol 2011; 57: 1375-1382.
33. Aaronson KD, et al: Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012; 125: 3191-3200.
34. Kormos RL, et al: Right ventricular failure in patients with the HeartMate II continuousflow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010; 139: 1316-1324.
35. Drakos SG, et al: Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol 2010; 105: 1030-1035.
36. Matthews JC, et al: The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 2008; 51: 2163-2172.
37. Krabatsch T, et al: Evaluation of the Heart-Ware HVAD centrifugal pump for right ventricular assistance in an in vitro model. ASAIO J 2011; 57: 183-187.
38. Krabatsch T, et al: Biventricular circulatory support with two miniaturized implantable assist devices. Circulation 2011; 124(suppl 11):S179-S186.
39. McGee EC Jr, et al: Biventricular continuous flow VADs demonstrate diurnal flow variation and lead to end-organ recovery. Ann Thorac Surg 2011; 92:e1-e3.
40. Krabatsch T, et al: Alternative technique for implantation of biventricular support with Hea rtWare implantable continuous flow pump. ASAIO J 2011; 57: 333-335.
41. Strueber M, et al: Successful use of the Heart-Ware HVAD rotary blood pump for biventricular support. J Thorac Cardiovasc Surg 2010; 140: 936-937.
42. Boyle AJ, et al: Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant 2011; 30: 402-407.
43. Baldwin JT, Mann DL: NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial. J Card Fail 2010; 16: 855-858.
44. John R, et al: Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. Ann Thorac Surg 2011; 92: 1406-1413, discussion 1413.
45. Kirklin JK, et al: Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg 2012; 144: 584-603, discussion 597-598.
46. Singh TP, et al: Decline in heart transplant wait list mortality in the United States following broader regional sharing of donor hearts. Circ Heart Fail 2012; 5: 249-258.